Notes
Slide Show
Outline
1
Experimental and Computational Requirements for Post-Genomic Integrative Cellular Physiology
  • John Wikswo
2
Topics
  • The advantages of micro/nanoscale instruments
  • Cellular complexity
  • The need for closed-loop control
  • How to identify early manifestations of disease
    • Modeling
    • Interactive, dynamical analysis
    • Mining dynamics data



3
Topics
  • The advantages of micro/nanoscale instruments
  • Cellular complexity
  • The need for closed-loop control
  • How to identify early manifestations of disease
    • Modeling
    • Interactive, dynamical analysis
    • Mining dynamics data
4
Reductionism in Science
5
Historical Evolution of Spatial Resolution in Biology and Physiology
  • X-Ray / SEM / STM
  • Optical microscope





  • Magnifying glass





  • Unaided eye
6
 
7
Hypotheses I and II

  • I.  The explosion in genomic and proteomic knowledge and measurement techniques will revolutionize the early detection of diseases


  • II.  Much of the potential lies in the clinical implementation of the instrumentation and techniques that provided the scientific foundation for genomics and proteomics


8
Technologies for Early Disease Detection
  • Analysis of biofluids
    • Molecular profiles that define biological states (Dahl)
    • Disposable plastic lab-on-a-chip devices for point-of-care systems  (Luke Lee)
    • Indwelling biosensors and analyzers (Stephen C. Lee)
    • Chemokine and cytokine expression (Barrett Rollins; Philip R. Streeter)
    • Gene expression patterns (Carl W. Cotman; Marti Jett)
    • Detection of mutant alleles (Helmut Zarbl)
    • Protein expression/distribution (Philip R. Streeter; Gordon R. Whiteley)
  • Single-pass analysis of proteins, cells and tissues
    • Detection of small numbers of molecules (Roger Brent)
    • Multispectral cellular imaging (David Basiji)
    • Protein distribution in tissues (Richard Caprioli)
  • Interactive cellular assays for systems biology
    • Disease/pathogen-induced changes in cells (Christopher Chen)
    • Nanoscale sensing of single molecule binding (Michael Roukes)
    • Massively Parallel, Multi-Phasic Cellular Biological activity detectors (John Wikswo)
9
Technologies for Early Disease Detection
  • Analysis of biofluids
    • Molecular profiles that define biological states (Dahl)
    • Disposable plastic lab-on-a-chip devices for point-of-care systems  (Luke Lee)
    • Indwelling biosensors and analyzers (Stephen C. Lee)
    • Chemokine and cytokine expression (Barrett Rollins; Philip R. Streeter)
    • Gene expression patterns (Carl W. Cotman; Marti Jett)
    • Detection of mutant alleles (Helmut Zarbl)
    • Protein expression/distribution (Philip R. Streeter; Gordon R. Whiteley)
  • Single-pass analysis of cells and tissues
    • Detection of small numbers of molecules (Roger Brent)
    • Multispectral cellular imaging (David Basiji)
    • Protein distribution in tissues (Richard Caprioli)


  • Key Features:
    • Low temporal bandwidth sensing
      • Slow events, long measurement intervals or single-pass imaging
    • Semi-standard, static biochemical analyses
      • Feature correlation and pattern recognition
    • Will benefit directly from advances in genomics and proteomics
    • May involve significant issues in bioinformatics
    • Will benefit from Micro/Nano
10
Standard Rationale for Micro & Nanoscale Analytical Systems
  • BioMicroElectroMechanical Systems (BioMEMS)
  • Low-cost mass production
  • Automated analysis
  • Reduced instrument footprint
    • Single instruments are very, very small
    • Reduced volumes of analyte and reagents
    • Massively parallel
      • Increased data
      • Lower cost per datum
      • Combinatorics for frontal assault on multivariable systems
  • Enabling new physical/chemical properties
    • Single molecule detection
    • Quantum dots
11
"~2,000 valves to control"
  • ~2,000 valves to control
    • Reagents
    • Samples
    • Wash steps
    • www.fluidigm.com
12
 
13
 
14
 
15
Genomics

Proteomics

What is next?
16
Topics
  • The advantages of micro/nanoscale instruments
  • Cellular complexity
  • The need for closed-loop control
  • How to identify early manifestations of disease
    • Modeling
    • Interactive, dynamical analysis
    • Mining dynamics data
17
Hypotheses III and IV

  • III.  Historically, dynamical studies of cellular metabolism and signaling pathways have been limited by the bandwidth of laboratory biochemistry


  • IV.  BioMicroElectroMechanical Systems (BioMEMS) offer promise to extend the measurement bandwidth for both research and clinical diagnosis
18
Technologies for Early Disease Detection
  • Interactive cellular assays for systems biology
    • Disease/pathogen-induced changes in cells (Christopher Chen)
    • Nanoscale sensing of single molecule binding (Michael Roukes)
    • Massively Parallel, Multi-Phasic Cellular Biological Activity Detectors (John Wikswo)


  • Key Features:
    • More closely related to experimental physiology than classical clinical biochemistry
    • Can involve rapid sensing of physiological dynamics
    • Measurement bandwidth << physiological bandwidth
    • Real-time intervention is REQUIRED to probe the dynamics
      • Internal vs. external feedback
      • “Bandwidth is everything”
    • May require models for interpretation of complex interactions
      • There may be significant computational contraints to multiscale dynamical models
19
Post-Reductionism
20
What about dynamic processes?
  • Physiology is dynamic
    • Cell cycle
    • Developmental differentiation
    • Growth
    • Voltage- and ligand-gates ion channels
      • Propagating waves
      • Signaling cascades
    • Closed-loop feedback and control
21
Cytion Planar Patch Clamp
  • Courtesy of Christian Schmidt and Will Lachnit
22
Array of Ion Channels
  • Courtesy of Ananta Krishnan, DARPA
23
Physical and Biological Time Constants, Seconds

  • Mixing time to homogenize liquid in a large-scale bioreactor (10-100 m3)  104 -108
  • 90% liquid volume exchange in in a continuous reactor 105 -106
  • Oxygen transfer (forced not free diffusion) 102 -103
  • Heat transfer (forced convection) 103 - 104


  • Cell proliferation, DNA replication 102 -104
  • Response to environmental changes (temperature, oxygen) 103 -104
  • Messenger RNA synthesis 103 -104
  • Translocation of substances into cells (active transport) 101 -103
  • Protein synthesis 101 -102
  • Allosteric control of enzyme action 1


  • Glycolysis 10-1 -10-2
  • Oxidative phosphorylation in mitochondria 10-2
  • Intracellular quiescent mass & heat transfer (dimension 10-5 m) 10-5 -10-3
  • Enzymatic reaction and turnover 10-6 -10-3
  • Bonding between enzyme & substrate, inhibitor 10-6
  • Receptor-ligand interaction 10-6
24
The Systems Physiology Challenge
  • Use experimental measurements, numerical simulations, and knowledge of the genome and proteome to unravel the complex, multiscale interactions and dynamics in normal physiology, toxic exposures, and disease
    • Metabolic networks
    • Intracellular and extracellular signaling
      • Gene expression
      • Protein interactions
      • Cell-cell interactions
      • Active transport
    • Development, growth, aging, death
25
Biological Modeling and Analysis
26
Postgenomic Integrative/Systems Physiology/Biology
  • Specify concentrations and
  • Rate constants
  • Add gene expression,
  • Protein interactions, and
  • Signaling pathways;
  • Include intracellular spatial distributions, diffusion, and transport,
  • … and calculate how the target cell behaves in response to a toxin or pathogen
27
 
28
Molecular Interaction Map: DNA Repair
29
Molecular Interaction Map: Cell Cycle
30
The Catch
  • Modeling of a single mammalian cell may require 100,000 variables and equations
  • Cell-cell interactions are critical to system function
  • 109 interacting cells in some organs
  • Models may be leibnitz-class
  • The data don’t yet exist to drive the models!
  • Hence we need to experiment…


  • *1 leibnitz = 1 mole of PDEs ~ 1 etaFLOPS-year
31
Topics
  • The advantages of micro/nanoscale instruments
  • Cellular complexity
  • The need for closed-loop control
  • How to identify early manifestations of disease
    • Modeling
    • Interactive, dynamical analysis
    • Mining dynamics data
32
The Experimental Problem
  • Most chemical and metabolic sensors and actuators
    • Are too slow to track biochemical events at the cellular level
    • Are made one at a time
  • Biological systems contain extensive closed-loop, multilevel, feedback and control
    • Simple, single-step observations cannot discern how control is distributed through the system.
    • Closed-loop metabolic control is today possible only at the animal and organ level, e.g., glucose clamp
    • Chemical control is limited by diffusion, stirring, uncaging rates, or the time required to move a cell from one medium to another
  • Post-genomic physiology needs multiparameter, wide-bandwidth cellular metabolic and signaling sensing and control
33
What do we need?
  • Simultaneous, fast sensors                             (transducers) that detect a                        variety of changes within                                  and outside the cell
  • Actuators that control the             microenvironment within and outside the cell
  • Openers for the internal feedback loops
  • System algorithms and models that allow you to close and stabilize the external feedback loop
  • …
34
The Challenge: Instrument and Control the Cell
  • Develop the tools and techniques for integrative, post-genomic cellular biology
    • Genes
    • Proteins
    • Metabolic and signaling pathways
    • Instruments
    • Models
    • Wide-bandwidth dynamic control theory for cellular systems
  • How do normal and diseased cells function?
35
Instrumenting the Single Cell
  • Arrays of instrumented single or multiple cells:  Rapid, sensitive, and accurate differential diagnosis of cellular pathophysiology
  • Cellular dynamics: Discrimination between causal and  secondary events
  • Functional biopsy: Determine the state of specific physiological pathways and mechanisms affected by an as-yet undetected disease, and thus define a prophylaxis or therapy.
  • Artificial, minimal cells: engineered to serve as dedicated, configurable, robust on-chip biosensors.
  •   “Quantitative physiology at the speed of life,” C. Kovac
36
Possible Approaches
  • A biological cell or molecule inserted into a microinstrument, e.g., a single-cell spectrophotometer or a whole-cell patch clamp
  • A nanoinstrument inserted into the cell/molecule, e.g., caged ATP
  • Combine the two approaches to form an FAST integrated, closed-loop bio/nano/micro system
37
MicroBottle
  • Goal – utilize proven gigaOhm seals to biological membranes
  • Result – high-speed microfluidics and silicon microelectronics can be placed “inside” a living cell
38
Hypotheses V and VI
  • V.  Great advances in physiology have been made through opening physiological feedback loops and applying external control
    • Frank-Starling cardiovascular regulation
    • Glucose/insulin regulation
    • Hodgkin-Huxley model of the nerve action potential
  • VI.  There will exist a class of diseases or susceptibilities to drugs or toxins that can be diagnosed through altered cellular dynamics
39
Physical and Biological Time Constants, Seconds

  • Mixing time to homogenize liquid in a large-scale bioreactor (10-100 m3)  104 -108
  • 90% liquid volume exchange in in a continuous reactor 105 -106
  • Oxygen transfer (forced not free diffusion) 102 -103
  • Heat transfer (forced convection) 103 - 104


  • Cell proliferation, DNA replication 102 -104
  • Response to environmental changes (temperature, oxygen) 103 -104
  • Messenger RNA synthesis 103 -104
  • Translocation of substances into cells (active transport) 101 -103
  • Protein synthesis 101 -102
  • Allosteric control of enzyme action 1


  • Glycolysis 10-1 -10-2
  • Oxidative phosphorylation in mitochondria 10-2
  • Intracellular quiescent mass & heat transfer (dimension 10-5 m) 10-5 -10-3
  • Enzymatic reaction and turnover 10-6 -10-3
  • Bonding between enzyme & substrate, inhibitor 10-6
  • Receptor-ligand interaction 10-6
40
A Key Rationale for Micro & Nanoscale Analytical Systems
  • Wide measurement bandwidth, i.e., good  response to high frequencies, is required to track fast cellular events
  • Stable control of fast systems requires high bandwidth
  • Small is the best way to beat the time for diffusional mixing in large-scale assays
  • Small lets one look at individual cellular events rather than ensemble averages


41
Lactate Diffusion Times
42
What do we gain by small and fast?
  • Electrochemical sensitivity scale-invarient; frequency response improves as size is decreased
  • Decreased mixing times for mass and heat transfer
  • Reduced reagent volumes for rapid injection
  • Many nanocultures within a single device
  • Monitor known, small (N=1?) number of cells in each nanoculture
  • Array of NanoBioReactors, in parallel, in series, and with redundancy for high-content screening
43
Chemical Clamp
  • Sensors: Advanced micro and                                       nanosensors can quantify the extra-                           cellular and intra-cellular                                          environments with unprecedented                                temporal resolution
  • Actuators: Microfluidics can control extracellular and intracellular concentrations of key chemicals with millisecond-response picoliter pumps
  • Openers: RNAi, genetic knockouts, and blockers will allow opening of the internal feedback loop
  • Controllers: It will be possible to create high-speed extracellular and intracellular chemical clamps functionally equivalent to voltage clamp for Vm
44
High-Content Toxicology Screening Using
Massively Parallel, Multi-Phasic Cellular Biological Activity Detector
 (MP2-CBAD)
  • Vanderbilt University
  • Departments of Biomedical Engineering, Chemical Engineering, Chemistry, Mechanical Engineering, Molecular Physiology & Biophysics, Physics & Astronomy
45
Cell Metabolism
46
Discrimination
47
     Vanderbilt Instrumenting the Single Cell
48
Coupled Modeling of Cell and Environment
49
The Challenge: Convert Steady-State Metabolic Flux Balances to Dynamic Metabolic Network Responses
50
Bio-Molecular Devices/Systems
  • Courtesy of Ananta Krishnan, DARPA
51
Bio-Molecular Devices/Systems
52
Topics
  • The advantages of micro/nanoscale instruments
  • Cellular complexity
  • The need for closed-loop control
  • How to identify early manifestations of disease
    • Modeling
    • Interactive, dynamical analysis
    • Mining dynamics data
53
Biological Modeling and Analysis
54
Signal Classification: Feature Extraction
55
Agent Discrimination Algorithms
56
Data Mining/Exploration
57
Conclusions
  • Micro/Nano will “increase throughput and automation, reducing cost per analysis, and enabling entirely new applications.”  C. Dahl
  • Understanding cellular dynamics is key to understanding cellular physiology
  • Micro/Nano will enable closed-loop control of certain cellular functions
  • Biology and biochemistry can serve as preamplifiers for biological, biochemical, and biophysical detectors
    • PCR of course, but what else?
  • Cell harvesting may be a problem for many tissues
    • Physiological biopsy
    • Pretransplant certification (pancreatic beta cells in islet transplants)
    • Well suited for probing drug interactions for particular phenotypes
  • Dynamic model complexity is a major challenge
    • Specification
    • Verification